| __timestamp | Arrowhead Pharmaceuticals, Inc. | Johnson & Johnson |
|---|---|---|
| Wednesday, January 1, 2014 | 23138050 | 8494000000 |
| Thursday, January 1, 2015 | 57410147 | 9046000000 |
| Friday, January 1, 2016 | 41454452 | 9095000000 |
| Sunday, January 1, 2017 | 31690298 | 10554000000 |
| Monday, January 1, 2018 | 52968505 | 10775000000 |
| Tuesday, January 1, 2019 | 81048686 | 11355000000 |
| Wednesday, January 1, 2020 | 128874979 | 12340000000 |
| Friday, January 1, 2021 | 206342000 | 14277000000 |
| Saturday, January 1, 2022 | 297307000 | 14135000000 |
| Sunday, January 1, 2023 | 353188000 | 15048000000 |
| Monday, January 1, 2024 | 505870000 | 17232000000 |
Igniting the spark of knowledge
In the ever-evolving landscape of pharmaceuticals, innovation is the lifeblood that drives progress. Over the past decade, Johnson & Johnson and Arrowhead Pharmaceuticals, Inc. have demonstrated contrasting approaches to research and development (R&D) investments. From 2014 to 2023, Johnson & Johnson consistently allocated substantial resources to R&D, with expenditures peaking at approximately $15 billion in 2023. This represents a steady increase of around 77% from their 2014 investment.
Conversely, Arrowhead Pharmaceuticals, Inc. has shown a remarkable growth trajectory in its R&D spending, starting from a modest $23 million in 2014 and surging to over $500 million by 2024. This represents an astounding increase of over 2,000%, highlighting their aggressive push towards innovation. While Johnson & Johnson's investments dwarf those of Arrowhead in absolute terms, the latter's rapid growth underscores its commitment to pioneering advancements in the pharmaceutical sector.
Johnson & Johnson vs Merck & Co., Inc.: Strategic Focus on R&D Spending
R&D Spending Showdown: Johnson & Johnson vs Bristol-Myers Squibb Company
Research and Development Investment: Johnson & Johnson vs Pfizer Inc.
Who Prioritizes Innovation? R&D Spending Compared for Johnson & Johnson and Zoetis Inc.
Research and Development Investment: Johnson & Johnson vs Catalyst Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Johnson & Johnson and Celldex Therapeutics, Inc.
Teva Pharmaceutical Industries Limited vs Arrowhead Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Summit Therapeutics Inc. vs Arrowhead Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Exelixis, Inc. and Arrowhead Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Ascendis Pharma A/S vs Arrowhead Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Pharming Group N.V. vs Arrowhead Pharmaceuticals, Inc.
R&D Spending Showdown: Perrigo Company plc vs Arrowhead Pharmaceuticals, Inc.